X4 Pharmaceuticals

XFOR

Börsenwert 319 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	11,2 Mio. $	–	–	–
2	2 OrbiMed New York	7,36 Mio. $	–	–	–
3	3 BlackRock New York	6,68 Mio. $	+105.001 $	+438	+1 %
4	4 BVF Inc San Francisco, California	5,37 Mio. $	-1,74 Mio. $	-7.266	-22 %
5	5 Ikarian Capital Dallas, Texas	4,91 Mio. $	+5,75 Mio. $	+23.989	+14.365 %
6	6 Vanguard Group Malvern, Pennsylvania	4,86 Mio. $	-25.891 $	-108	-0,4 %
7	7 RA Capital Management Boston, Massachusetts	3,79 Mio. $	–	–	–
8	8 Axa Paris, France	3,7 Mio. $	+196.337 $	+819	+5 %
9	9 State Street Boston, Massachusetts	2,86 Mio. $	+22.295 $	+93	+0,7 %
10	10 New Leaf Venture Partners New York	2,27 Mio. $	–	–	–
11	11 Polaris Venture Management Co V Boston, Massachusetts	2,11 Mio. $	–	–	–
12	12 SV Health Investors Boston, Massachusetts	2,11 Mio. $	–	–	–
13	13 Geode Capital Management Boston, Massachusetts	1,64 Mio. $	+120.104 $	+501	+7 %
14	14 Northern Trust Chicago, Illinois	1,56 Mio. $	-79.350 $	-331	-4 %
15	15 Fidelity Investments Boston, Massachusetts	1,5 Mio. $	-3,8 Mio. $	-15.863	-68 %
16	16 Renaissance Technologies New York	1,06 Mio. $	+425.038 $	+1.773	+52 %
17	17 Nuveen Charlotte, North Carolina	562.000 $	+3.356 $	+14	+0,5 %
18	18 Boothbay Fund Management New York	520.000 $	+613.464 $	+2.559	Neu
19	OM 19 Opaleye Management Boston, Massachusetts	508.000 $	+599.320 $	+2.500	Neu
20	20 Alyeska Investment Group Chicago, Illinois	456.000 $	–	–	–
21	21 Panagora Asset Management Boston, Massachusetts	455.000 $	+122.981 $	+513	+30 %
22	22 Zacks Investment Management Chicago, Illinois	379.000 $	-161.337 $	-673	-27 %
23	23 Goldman Sachs New York	348.000 $	+158.460 $	+661	+63 %
24	24 Bank of New York Mellon New York	333.000 $	+9.829 $	+41	+3 %
25	25 ClariVest Asset Management San Diego, California	309.000 $	+49.384 $	+206	+16 %

X4 Pharmaceuticals XFOR Börsenwert 319 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 319 Mio. $